» Articles » PMID: 35473693

Pulmonary Hypertension and Oxidative Stress: Where is the Link?

Overview
Publisher Elsevier
Date 2022 Apr 27
PMID 35473693
Authors
Affiliations
Soon will be listed here.
Abstract

Oxidative stress can be associated with hyperoxia and hypoxia and is characterized by an increase in reactive oxygen (ROS) and nitrogen (RNS) species generated by an underlying disease process or by supplemental oxygen that exceeds the neutralization capacity of the organ system. ROS and RNS acting as free radicals can inactive several enzymes and vasodilators in the nitric oxide pathway promoting pulmonary vasoconstriction resulting in persistent pulmonary hypertension of the newborn (PPHN). Studies in animal models of PPHN have shown high ROS/RNS that is further increased by hyperoxic ventilation. In addition, antioxidant therapy increased PaO in these models, but clinical trials are lacking. We recommend targeting preductal SpO between 90 and 97%, PaO between 55 and 80 mmHg and avoiding FiO > 0.6-0.8 if possible during PPHN management. This review highlights the role of oxidative and nitrosative stress markers on PPHN and potential therapeutic interventions that may alleviate the consequences of increased oxidant stress during ventilation with supplemental oxygen.

Citing Articles

Effectiveness and safety of the use of sodium nitrite in patients with hypertension and pulmonary hypertension: a scoping review.

Ribeiro J, Santana A, de Oliveira Marusso L, de Oliveira Marrafon D, Dos Reis T, Rosalen P Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39873718 DOI: 10.1007/s00210-025-03796-7.


Mechanisms Controlling the Behavior of Vascular Smooth Muscle Cells in Hypoxic Pulmonary Hypertension.

Bacakova L, Sedlar A, Musilkova J, Eckhardt A, Zaloudikova M, Kolar F Physiol Res. 2024; 73(S2):S569-S596.

PMID: 39589304 PMC: 11627264.


Pulmonary Hypertension: Pharmacological and Non-Pharmacological Therapies.

Tsai J, Malik S, Tjen-A-Looi S Life (Basel). 2024; 14(10).

PMID: 39459565 PMC: 11509317. DOI: 10.3390/life14101265.


Occurrence of hyperoxia during iNO treatment for persistent pulmonary hypertension of the newborn: a cohort study.

de Jager J, Brouwer F, Reijman J, Van Der Palen R, Steggerda S, Visser R Eur J Pediatr. 2024; 183(5):2455-2461.

PMID: 38470520 PMC: 11035448. DOI: 10.1007/s00431-024-05506-6.


Inhaled Nitric Oxide in Neonatal Pulmonary Hypertension.

Cookson M, Kinsella J Clin Perinatol. 2024; 51(1):95-111.

PMID: 38325949 PMC: 10954355. DOI: 10.1016/j.clp.2023.11.001.


References
1.
Konduri G, Bakhutashvili I, Eis A, Pritchard Jr K . Oxidant stress from uncoupled nitric oxide synthase impairs vasodilation in fetal lambs with persistent pulmonary hypertension. Am J Physiol Heart Circ Physiol. 2006; 292(4):H1812-20. DOI: 10.1152/ajpheart.00425.2006. View

2.
Lakshminrusimha S, Russell J, Wedgwood S, Gugino S, Kazzaz J, Davis J . Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension. Am J Respir Crit Care Med. 2006; 174(12):1370-7. PMC: 2111046. DOI: 10.1164/rccm.200605-676OC. View

3.
Steinhorn R, Russell J, Morin 3rd F . Disruption of cGMP production in pulmonary arteries isolated from fetal lambs with pulmonary hypertension. Am J Physiol. 1995; 268(4 Pt 2):H1483-9. DOI: 10.1152/ajpheart.1995.268.4.H1483. View

4.
Panfoli I, Candiano G, Malova M, De Angelis L, Cardiello V, Buonocore G . Oxidative Stress as a Primary Risk Factor for Brain Damage in Preterm Newborns. Front Pediatr. 2018; 6:369. PMC: 6281966. DOI: 10.3389/fped.2018.00369. View

5.
Rhoades R, Packer C, Roepke D, Jin N, Meiss R . Reactive oxygen species alter contractile properties of pulmonary arterial smooth muscle. Can J Physiol Pharmacol. 1990; 68(12):1581-9. DOI: 10.1139/y90-241. View